LNC (Life insurers) Stock Valuation & Fair Value
Mixed on our testsLNC (Life insurers) trades at a current P/E of 5.1, about 38% below its historical normal valuation, with a forward growth estimate of 9.1% and a PEG of 0.57. Analysts' one-year estimates have been hit 36% of the time. Priced at its historical normal P/E of 8.3 on the same blended earnings, the 2026-10-30 close of $41.01 corresponds to about $66.30 a share. This is a valuation reference, not a price target.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
Valuation flags
- Misses analyst estimates often (55%)
Frequently asked questions
Is LNC overvalued?
At a current P/E of 5.1 versus its historical normal P/E of 8.3, LNC trades about 38% below its typical valuation, with a PEG of 0.57 on 9.1% forward growth. tickerseer currently rates it mixed on our tests.
What is LNC's fair value and PEG?
LNC trades at a current P/E of 5.1 against a historical normal P/E of 8.3, a PEG of 0.57, and a forward growth estimate of 9.1%. Priced at its historical normal P/E of 8.3 on the same blended earnings, the 2026-10-30 close of $41.01 corresponds to about $66.30 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of LNC changed?
tickerseer's rating has been mixed on our tests since 2026-10-31.
Industry: Life insurers. Create a free account to see the full analysis: the SeerAI score, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.